scispace - formally typeset
D

Dominik Eichin

Researcher at University of Turku

Publications -  6
Citations -  70

Dominik Eichin is an academic researcher from University of Turku. The author has contributed to research in topics: Lymphatic system & Macrophage polarization. The author has an hindex of 3, co-authored 6 publications receiving 32 citations.

Papers
More filters
Journal ArticleDOI

CD73 Activity is Dispensable for the Polarization of M2 Macrophages

TL;DR: These data indicate that, in contrast to other major leukocyte subpopulations, CD73 activity on macrophages does not play a major role in their polarization and that in mice host CD73 on any cell type is not required in vivo for peritoneal macrophage polarization towards either a pro- or an anti-inflammatory direction.
Journal ArticleDOI

Lymphatic Endothelial Cell Activation and Dendritic Cell Transmigration Is Modified by Genetic Deletion of Clever-1.

TL;DR: In this article, the authors demonstrated that Clever-1 is immunosuppressive towards migrating dendritic cells and thus regulates the magnitude of immune responses created by incoming DCs in the draining lymph nodes.
Journal ArticleDOI

Self-Synthesizing Nanorods from Dynamic Combinatorial Libraries against Drug Resistant Cancer.

TL;DR: The findings suggested that harnessing the interplay between synthesis and self-assembly in complex chemical systems could yield functional nanomaterials for advanced applications.
Journal ArticleDOI

CD73 contributes to anti‐inflammatory properties of afferent lymphatic endothelial cells in humans and mice

TL;DR: It is revealed that a previously unknown role of CD73 on afferent lymphatics is to dampen immune responses, and a low likelihood of endothelial cell–related adverse effects by CD73 targeting therapeutic antibodies is indicated.
Journal ArticleDOI

Evaluation of [ 18 F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy

TL;DR: In this article, the authors evaluated whether N,N-diethyl-2-(2-(4-([18F]fluoro)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide (F-DPA) can reflect radiotherapy-induced changes in TSPO activity in head and neck squamous cell carcinoma (HNSCC).